271 related articles for article (PubMed ID: 24323037)
1. Adverse event reporting in cancer clinical trial publications.
Sivendran S; Latif A; McBride RB; Stensland KD; Wisnivesky J; Haines L; Oh WK; Galsky MD
J Clin Oncol; 2014 Jan; 32(2):83-9. PubMed ID: 24323037
[TBL] [Abstract][Full Text] [Related]
2. Reporting quality of abstracts in phase III clinical trials of systemic therapy in metastatic solid malignancies.
Sivendran S; Newport K; Horst M; Albert A; Galsky MD
Trials; 2015 Aug; 16():341. PubMed ID: 26253548
[TBL] [Abstract][Full Text] [Related]
3. The reporting of harms in publications on randomized controlled trials funded by the "Programme Hospitalier de Recherche Clinique," a French academic funding scheme.
Favier R; Crépin S
Clin Trials; 2018 Jun; 15(3):257-267. PubMed ID: 29498543
[TBL] [Abstract][Full Text] [Related]
4. The use of and adherence to CTCAE v3.0 in cancer clinical trial publications.
Zhang S; Chen Q; Wang Q
Oncotarget; 2016 Oct; 7(40):65577-65588. PubMed ID: 27564109
[TBL] [Abstract][Full Text] [Related]
5. Completeness of reporting in randomized controlled trials of 3 vaccines: a review of adherence to the CONSORT checklist.
Scott P; Ott F; Egger M; Low N
Pediatr Infect Dis J; 2012 Dec; 31(12):1286-94. PubMed ID: 22935870
[TBL] [Abstract][Full Text] [Related]
6. Reporting of harms by randomised controlled trials in ophthalmology.
O'Day R; Walton R; Blennerhassett R; Gillies MC; Barthelmes D
Br J Ophthalmol; 2014 Aug; 98(8):1003-8. PubMed ID: 24515989
[TBL] [Abstract][Full Text] [Related]
7. Quality of reporting in randomized trials published in high-quality surgical journals.
Sinha S; Sinha S; Ashby E; Jayaram R; Grocott MP
J Am Coll Surg; 2009 Nov; 209(5):565-571.e1. PubMed ID: 19854395
[TBL] [Abstract][Full Text] [Related]
8. A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature.
Scales CD; Norris RD; Keitz SA; Peterson BL; Preminger GM; Vieweg J; Dahm P
J Urol; 2007 Mar; 177(3):1090-4; discussion 1094-5. PubMed ID: 17296417
[TBL] [Abstract][Full Text] [Related]
9. Adherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: a systematic review.
Péron J; Maillet D; Gan HK; Chen EX; You B
J Clin Oncol; 2013 Nov; 31(31):3957-63. PubMed ID: 24062406
[TBL] [Abstract][Full Text] [Related]
10. Reporting of harm in randomized controlled trials published in the urological literature.
Breau RH; Gaboury I; Scales CD; Fesperman SF; Watterson JD; Dahm P
J Urol; 2010 May; 183(5):1693-7. PubMed ID: 20299044
[TBL] [Abstract][Full Text] [Related]
11. Reporting adverse events in randomized controlled trials.
Nuovo J; Sather C
Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):349-51. PubMed ID: 16998947
[TBL] [Abstract][Full Text] [Related]
12. Reporting of safety results in published reports of randomized controlled trials.
Pitrou I; Boutron I; Ahmad N; Ravaud P
Arch Intern Med; 2009 Oct; 169(19):1756-61. PubMed ID: 19858432
[TBL] [Abstract][Full Text] [Related]
13. Evaluating single-incision slings in female stress urinary incontinence: the usefulness of the CONSORT statement criteria.
Diallo S; Cour F; Josephson A; Vidart A; Botto H; Lebret T; Bonan B
Urology; 2012 Sep; 80(3):535-41. PubMed ID: 22925231
[TBL] [Abstract][Full Text] [Related]
14. Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: an ACTTION systematic review.
Smith SM; Chang DR; Pereira A; Shah N; Gilron I; Katz NP; Lin AH; McDermott MP; Rappaport BA; Rowbotham MC; Sampaio C; Turk DC; Dworkin RH
Pain; 2012 Dec; 153(12):2415-2421. PubMed ID: 22985899
[TBL] [Abstract][Full Text] [Related]
15. The reporting of adverse events following spinal manipulation in randomized clinical trials-a systematic review.
Gorrell LM; Engel RM; Brown B; Lystad RP
Spine J; 2016 Sep; 16(9):1143-51. PubMed ID: 27241208
[TBL] [Abstract][Full Text] [Related]
16. Reporting Quality of Randomized, Controlled Trials Evaluating Combined Chemoradiotherapy in Nasopharyngeal Carcinoma.
Chen YP; Chen L; Li WF; Lee AWM; Vermorken JB; Wee J; O'Sullivan B; Eisbruch A; Lin JC; Mai HQ; Zhang L; Guo Y; Lin AH; Sun Y; Ma J
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):170-176. PubMed ID: 28586958
[TBL] [Abstract][Full Text] [Related]
17. The REFLECT statement: reporting guidelines for Randomized Controlled Trials in livestock and food safety: explanation and elaboration.
Sargeant JM; O'Connor AM; Gardner IA; Dickson JS; Torrence ME;
Zoonoses Public Health; 2010 Mar; 57(2):105-36. PubMed ID: 20070652
[TBL] [Abstract][Full Text] [Related]
18. Quality of reporting in clinical trials of preharvest food safety interventions and associations with treatment effect.
Sargeant JM; Saint-Onge J; Valcour J; Thompson A; Elgie R; Snedeker K; Marcynuk P
Foodborne Pathog Dis; 2009 Oct; 6(8):989-99. PubMed ID: 19630508
[TBL] [Abstract][Full Text] [Related]
19. Adverse event reporting in publications compared with sponsor database for cancer clinical trials.
Scharf O; Colevas AD
J Clin Oncol; 2006 Aug; 24(24):3933-8. PubMed ID: 16921045
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the quality of publications on randomized clinical trials using the Consolidated Standards of Reporting Trials (CONSORT) statement guidelines in a Spanish tertiary hospital.
Dasí F; Navarro-García MM; Jiménez-Heredia M; Magraner J; Viña JR; Pallardó FV; Cervantes A; Morcillo E
J Clin Pharmacol; 2012 Jul; 52(7):1106-14. PubMed ID: 21593281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
